Thu, November 16, 2023

Andreas Argyrides Upgraded (UBX) to Buy on, Nov 16th, 2023

Andreas Argyrides of Wedbush, Upgraded "Unity Biotechnology, Inc." (UBX) to Buy on, Nov 16th, 2023.

Andreas has made no other calls on UBX in the last 4 months.



There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Andreas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andreas


  • Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Tuesday, November 14th, 2023